A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size

Pharmacogenetics and Genomics

Volumn 20, Issue 5, 2010, Pages 291-297

  Lötsch, Jörn ^a   Prüss, Harald ^b   Veh, Rüdiger W ^b   Doehring, Alexandra ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Addiction; Opioid pharmacodynamics; Pain

Indexed keywords

DIAMORPHINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; LEVOMETHADONE; MORPHINE; OPIATE; PROTEIN KCNJ6; UNCLASSIFIED DRUG;

ADDICTION; ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUPIL; WITHDRAWAL SYNDROME;

RATTUS;

EID: 77951498644     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283386bda     Document Type: Article

References (23)

1. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413:203-210. (Pubitemid 32867885)
2. Lacroix-Fralish ML, Ledoux JB, Mogil JS. The pain genes database: an interactive web browser of pain-related transgenic knockout studies. Pain 2007; 131:3e1-3e4.
3. Mitrovic I, Margeta-Mitrovic M, Bader S, Stoffel M, Jan LY, Basbaum AI. Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences. Proc Natl Acad Sci USA 2003; 100:271-276. (Pubitemid 36078064)
4. Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, Yoshioka T, et al. Ethanol opens G-protein-activated inwardly rectifying K + channels. Nat Neurosci 1999; 2:1091-1097. (Pubitemid 30126367)
5. Marker CL, Stoffel M, Wickman K. Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. J Neurosci 2004; 24:2806-2812. (Pubitemid 38380958)
6. Nishizawa D, Nagashima M, Katoh R, Satoh Y, Tagami M, Kasai S, et al. Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS One 2009; 4:e7060.
7. Doehring A, Hentig N, Graff J, Salamat S, Schmidt M, Geisslinger G, et al. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics 2009; 19:407-414.
8. Lötsch J, von Hentig N, Freynhagen R, Griessinger N, Zimmermann M, Doehring A, et al. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenet Genomics 2009; 19:429-436.
9. Lötsch J, Skarke C, Wieting J, Oertel BG, Schmidt H, Brockmöller J, et al. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action. Clin Pharmacol Ther 2006; 79:72-89. (Pubitemid 43069580)
10. Avery CL, Martin LJ, Williams JT, North KE. Accuracy of haplotype estimation in a region of low linkage disequilibrium. BMC Genet 2005; 6 (Suppl 1):S80.
11. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989. (Pubitemid 32289743)
12. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265. (Pubitemid 40202029)
13. Twycross R, Wilcock A. Palliative care formulary. 3rd edition. Oxford: palliativebooks.com; 2007. p. 269.
14. Prüss H, Wenzel M, Eulitz D, Thomzig A, Karschin A, Veh RW. Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function. Brain Res Mol Brain Res 2003; 110:203-219. (Pubitemid 36184694)
15. Prüss H, Derst C, Lommel R, Veh RW. Differential distribution of individual subunits of strongly inwardly rectifying potassium channels (Kir2 family) in rat brain. Brain Res Mol Brain Res 2005; 139:63-79. (Pubitemid 41583590)
16. Eulitz D, Pruss H, Derst C, Veh RW. Heterogeneous distribution of kir3 potassium channel proteins within dopaminergic neurons in the mesencephalon of the rat brain. Cell Mol Neurobiol 2007; 27:285-302. (Pubitemid 46763877)
17. Kobayashi T, Washiyama K, Ikeda K. Modulators of G protein-activated inwardly rectifying K + channels: potentially therapeutic agents for addictive drug users. Ann N Y Acad Sci 2004; 1025:590-594. (Pubitemid 39643912)
18. Lewohl JM, Wilson WR, Mayfield RD, Brozowski SJ, Morrisett RA, Harris RA. G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci 1999; 2:1084-1090.
19. Hamshere ML, Green EK, Jones IR, Jones L, Moskvina V, Kirov G, et al. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry 2009; 195:23-29.
20. Cruz HG, Berton F, Sollini M, Blanchet C, Pravetoni M, Wickman K, et al. Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. J Neurosci 2008; 28:4069-4077.
21. Weschules DJ, Bain KT. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med 2008; 9:595-612.
22. Cohen J. A power primer. Psych Bull 1992; 112:155-159.
23. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008; 57:760-773. (Pubitemid 351335346)